1. Yan, Xin, Tian, Dayu, Peng, Rui, Zhou, Qin, Li, Qianyin. 2022. Tetratricopeptide repeat domain 36 protects renal tubular cells from cisplatin-induced apoptosis potentially via maintaining mitochondrial homeostasis. In Tissue & cell, 76, 101749. doi:10.1016/j.tice.2022.101749. https://pubmed.ncbi.nlm.nih.gov/35176677/
2. Zhou, Yuru, He, Qingling, Chen, Jihui, Gu, Yuping, Zhou, Qin. 2016. The expression patterns of Tetratricopeptide repeat domain 36 (Ttc36). In Gene expression patterns : GEP, 22, 37-45. doi:10.1016/j.gep.2016.11.001. https://pubmed.ncbi.nlm.nih.gov/27826126/
3. Jing, Wei, Peng, Ruoyu, Li, Xiaogai, Duan, Yu, Jiang, Shitao. 2022. Study on the Prognostic Values of TTC36 Correlated with Immune Infiltrates and Its Methylation in Hepatocellular Carcinoma. In Journal of immunology research, 2022, 7267131. doi:10.1155/2022/7267131. https://pubmed.ncbi.nlm.nih.gov/35846428/
4. Sgro, Agustin, Cursons, Joseph, Waryah, Charlene, Leedman, Peter J, Blancafort, Pilar. 2023. Epigenetic reactivation of tumor suppressor genes with CRISPRa technologies as precision therapy for hepatocellular carcinoma. In Clinical epigenetics, 15, 73. doi:10.1186/s13148-023-01482-0. https://pubmed.ncbi.nlm.nih.gov/37120619/